![]() |
![]() |
![]() 新型コロナウィルスSARS-CoV-2のタンパク質と関連化合物の立体構造 (HOMCOSサーバ) |
![]() |
![]() |
AC | ID | length (amino acids) |
short name | full name |
![]() |
A0A663DJA2_SARS2 | 38 | ||
![]() |
AP3A_SARS2 | 275 | ORF3a; | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; |
![]() |
NCAP_SARS2 | 419 | N; NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS6_SARS2 | 61 | ORF6; ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS2 | 121 | ORF7a; | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; |
![]() |
NS7B_SARS2 | 43 | ORF7b; | ORF7b protein; Accessory protein 7b; |
![]() |
NS8_SARS2 | 121 | ORF8; ns8; | ORF8 protein; Non-structural protein 8; |
![]() |
ORF9B_SARS2 | 97 | ORF9b; | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; |
![]() |
R1AB_SARS2 | 7096 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS2 | 4405 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS2 | 1273 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS2 | 75 | E;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS2 | 222 | M; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
Y14_SARS2 | 73 | ORF14; | Uncharacterized protein 14; |
![]() |
AP3A_SARS | 274 | ORF3a protein; Accessory protein 3a;Protein 3a;Protein U274;Protein X1; | |
![]() |
NCAP_SARS | 422 | NC ;Protein N ; | Nucleoprotein ; Nucleocapsid protein ; |
![]() |
NS3B_SARS | 154 | ns3b; | ORF3b protein; Accessory protein 3b;Non-structural protein 3b;Protein X2; |
![]() |
NS6_SARS | 63 | ns6; | ORF6 protein; Accessory protein 6;Non-structural protein 6;Protein X3; |
![]() |
NS7A_SARS | 122 | ORF7a protein; Accessory protein 7a;Protein U122;Protein X4; | |
![]() |
NS7B_SARS | 44 | ns7b; | Protein non-structural 7b; Accessory protein 7b; |
![]() |
NS8A_SARS | 39 | ns8a; | ORF8a protein; Accessory protein 8a;Protein non-structural 8a; |
![]() |
NS8B_SARS | 84 | ns8b; | ORF8b protein; Accessory protein 8b;Non-structural protein 8b; |
![]() |
ORF9B_SARS | 98 | ORF9b protein; Accessory protein 9b;ORF-9b;Protein 9b; | |
![]() |
R1AB_SARS | 7073 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
![]() |
R1A_SARS | 4382 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
![]() |
SPIKE_SARS | 1255 | S glycoprotein ; | Spike glycoprotein ; E2 ;Peplomer protein ; |
![]() |
VEMP_SARS | 76 | E protein ;sM protein ; | Envelope small membrane protein ; |
![]() |
VME1_SARS | 221 | M protein ; | Membrane protein ; E1 glycoprotein ;Matrix glycoprotein ;Membrane glycoprotein ; |
![]() |
Y14_SARS | 70 | Uncharacterized protein 14; | |
![]() |
ACE2_HUMAN | 805 | ACEH ;ACE-related carboxypeptidase; | Angiotensin-converting enzyme 2; Angiotensin-converting enzyme homolog ;Angiotensin-converting enzyme-related carboxypeptidase ;Metalloprotease MPROT15 {ECO:0000303|Ref.6}; |
![]() |
BST2_HUMAN | 180 | BST-2; | Bone marrow stromal antigen 2; HM1.24 antigen;Tetherin; |
![]() |
DDX1_HUMAN | 740 | DBP-RB; | ATP-dependent RNA helicase DDX1; DEAD box protein 1;DEAD box protein retinoblastoma; |
![]() |
FURIN_HUMAN | 794 | PACE; | Furin; Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme; |
![]() |
IMA1_HUMAN | 529 | Importin subunit alpha-1 ; Karyopherin subunit alpha-2;RAG cohort protein 1;SRP1-alpha; | |
![]() |
ITAL_HUMAN | 1170 | LFA-1A; | Integrin alpha-L; CD11 antigen-like family member A;Leukocyte adhesion glycoprotein LFA-1 alpha chain;Leukocyte function-associated molecule 1 alpha chain; |
![]() |
MPP5_HUMAN | 675 | MAGUK p55 subfamily member 5; | |
![]() |
PHB2_HUMAN | 299 | Prohibitin-2; B-cell receptor-associated protein BAP37;D-prohibitin;Repressor of estrogen receptor activity; | |
![]() |
PHB_HUMAN | 272 | Prohibitin ; | |
![]() |
SGTA_HUMAN | 313 | UBP; | Small glutamine-rich tetratricopeptide repeat-containing protein alpha; Alpha-SGT;Vpu-binding protein; |
![]() |
SMAD3_HUMAN | 425 | MAD homolog 3;Mad3;Mothers against DPP homolog 3;hMAD-3; SMAD 3;Smad3;hSMAD3; | Mothers against decapentaplegic homolog 3; JV15-2;SMAD family member 3; |
![]() |
TMPS2_HUMAN | 492 | Transmembrane protease serine 2 ; Serine protease 10 ; | |
![]() |
AMPN_HUMAN | 967 | AP-N;hAPN; AP-M; | Aminopeptidase N ; Alanyl aminopeptidase;Aminopeptidase M;Microsomal aminopeptidase;Myeloid plasma membrane glycoprotein CD13;gp150; |
![]() |
IL6RA_HUMAN | 468 | IL-6 receptor subunit alpha;IL-6R subunit alpha;IL-6R-alpha;IL-6RA; gp80; | Interleukin-6 receptor subunit alpha ; IL-6R 1;Membrane glycoprotein 80; |
![]() |
IL6RB_HUMAN | 918 | IL-6 receptor subunit beta;IL-6R subunit beta;IL-6R-beta;IL-6RB; gp130 ; | Interleukin-6 receptor subunit beta ; CDw130;Interleukin-6 signal transducer;Membrane glycoprotein 130;Oncostatin-M receptor subunit alpha; |
![]() |
IL6_HUMAN | 212 | IL-6; BSF-2;CDF;IFN-beta-2; | Interleukin-6 ; B-cell stimulatory factor 2;CTL differentiation factor;Hybridoma growth factor;Interferon beta-2; |
protein_id | length (amino acids) |
product | gene | note |
![]() |
7096 | 2'-O-ribose methyltransferase | orf1ab | pp1ab; translated by -1 ribosomal frameshift |
![]() |
180 | leader protein | nsp1; produced by both pp1a and pp1ab | |
![]() |
638 | nsp2 | produced by both pp1a and pp1ab | |
![]() |
1945 | nsp3 | former nsp1; conserved domains are: N-terminal | |
![]() |
500 | nsp4 | nsp4B_TM; contains transmembrane domain 2 (TM2); | |
![]() |
306 | 3C-like proteinase | nsp5A_3CLpro and nsp5B_3CLpro; main proteinase | |
![]() |
290 | nsp6 | nsp6_TM; putative transmembrane domain; produced by | |
![]() |
83 | nsp7 | produced by both pp1a and pp1ab | |
![]() |
198 | nsp8 | produced by both pp1a and pp1ab | |
![]() |
113 | nsp9 | ssRNA-binding protein; produced by both pp1a and | |
![]() |
139 | nsp10 | nsp10_CysHis; formerly known as growth-factor-like | |
![]() |
932 | RNA-dependent RNA polymerase | nsp12; NiRAN and RdRp; produced by pp1ab only | |
![]() |
601 | helicase | nsp13_ZBD, nsp13_TB, and nsp_HEL1core; zinc-binding | |
![]() |
527 | 3'-to-5' exonuclease | nsp14A2_ExoN and nsp14B_NMT; produced by pp1ab | |
![]() |
346 | endoRNAse | nsp15-A1 and nsp15B-NendoU; produced by pp1ab only | |
![]() |
298 | 2'-O-ribose methyltransferase | nsp16_OMT; 2'-o-MT; produced by pp1ab only | |
![]() |
4405 | nsp11 | orf1ab | pp1a |
![]() |
13 | nsp11 | produced by pp1a only | |
![]() |
1273 | surface glycoprotein | S | structural protein; spike protein |
![]() |
275 | ORF3a protein | ORF3a | |
![]() |
75 | envelope protein | E | ORF4; structural protein; E protein |
![]() |
222 | membrane glycoprotein | M | ORF5; structural protein |
![]() |
61 | ORF6 protein | ORF6 | |
![]() |
121 | ORF7a protein | ORF7a | |
![]() |
43 | ORF7b | ORF7b | |
![]() |
121 | ORF8 protein | ORF8 | |
![]() |
419 | nucleocapsid phosphoprotein | N | ORF9; structural protein |
![]() |
38 | ORF10 protein | ORF10 |
KEGG_ID | 構造式 | 一般名 | 商品名 | 効能 |
![]() |
D01703 シクレソニド (JAN); Ciclesonide (JAN/USAN/INN) | オルベスコ (帝人ファーマ) 00059259 | 喘息治療薬, 抗炎症薬, グルココルチコイド受容体作動薬 | |
![]() |
D01425 ロピナビル (JAN); Lopinavir (JAN/USP/INN) | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | ||
![]() |
D00427 リトナビル (JAN); Ritonavir (JAN/USP/INN) | ノービア (アッヴィ) 00059362 | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | |
![]() |
D09537 ファビピラビル (JAN); Favipiravir (JAN/USAN/INN) | アビガン (富士フイルム富山化学) 00066852 | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | |
![]() |
D09537_1 ファビピラビル・リボフラノシルリン酸体; Favipiravir-RMP; ファビピラビル活性体; | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D09537_2 ファビピラビル・リボフラノシル二リン酸体; Favipiravir-RDP; ファビピラビル活性体; | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D09537_3 ファビピラビル・リボフラノシル三リン酸体; Favipiravir-RTP; ファビピラビル活性体; | 抗ウイルス薬, RNAレプリカーゼ阻害薬 | ||
![]() |
D11472 レムデシビル (JAN); Remdesivir (JAN/USAN) | ベクルリー (ギリアド・サイエンシズ) 00068750 | 抗ウイルス薬, RNAポリメラーゼ阻害薬 | |
![]() |
D11472_1 レムデシビルリン酸体; Remdesivir-monophosphate (USAN | 抗ウイルス薬 | ||
![]() |
D11472_2 レムデシビル二リン酸体; Remdesivir-diphosphate (USAN | 抗ウイルス薬 | ||
![]() |
D11472_3 レムデシビル三リン酸体; Remdesivir-triphosphate (USAN | 抗ウイルス薬 | ||
![]() |
D02366 クロロキン; Chloroquine (USP/INN) | 抗マラリア薬, 抗アメーバ薬 | ||
![]() |
D08050 ヒドロキシクロロキン; Hydroxychloroquine (INN) | 抗マラリア薬 | ||
![]() |
D01670 ナファモスタットメシル酸塩 (JP17); Nafamostat mesylate (USAN); Nafamostat mesilate (JP17) | フサン (日医工) 00048710 | 抗凝固薬, 抗線溶薬, セリンプロテアーゼ阻害薬 | |
![]() |
D00429 サキナビル (JAN); Saquinavir (JAN/USP/INN) | 抗ウイルス薬, HIVプロテアーゼ阻害薬 | ||
![]() |
D01035 セファランチン (JAN); タマサキツヅラフジ抽出アルカロイド; Cepharanthine (JAN) | セファランチン (メディサ新薬) 00050591 セファランチン (メディサ新薬) 00060363 | 抗アレルギー薬, 血行促進薬 | |
![]() |
D00804 イベルメクチン (JAN); Ivermectin (JAN/USP/INN) | ストロメクトール (MSD) 00049234 | 抗寄生虫薬 | |
![]() |
D00292 デキサメタゾン (JP17); Dexamethasone (JP17/USP/INN) | アフタゾロン (あゆみ製薬) 00054356 デカドロン (日医工) 00054772 デカドロン (日医工) 00062800 レナデックス (セルジーン) 00058769 | 抗炎症薬, 鎮痒薬, グルココルチコイド受容体作動薬 | |
![]() |
D07486 アジスロマイシン; Azithromycin (INN) | 抗生物質, タンパク質合成阻害薬 |
HOMCOSは、現在、文部科学省の創薬等支援技術基盤プラットフォーム事業の支援を受け、大阪大学 蛋白研 蛋白質データベース研究室により開発・維持されています。
参考文献